600064 南京高科
2024/06 - 中期
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入1,045,931-62.31%4,733,0384,490,0614,934,5272,923,501
减:营业总成本1,007,854-62.15%4,564,9614,095,9564,688,8342,621,915
    其中:营业成本867,207-64.78%4,143,8663,649,0473,797,9871,745,096
               财务费用109,9003.20%220,384177,024203,312137,576
               资产减值损失----(608,242)(2,743)(72,938)(28,714)
公允价值变动收益(112,472)26.45%(140,770)(242,623)(34,410)792,231
投资收益1,057,246-7.32%1,964,6752,405,3342,367,1231,462,461
    其中:对联营企业和合营企业的投资收益1,107,6460.18%1,829,7262,096,3341,686,4581,358,636
营业利润976,185-15.50%1,367,5402,650,4142,679,0732,381,883
利润总额976,276-15.45%1,369,9622,651,6352,679,2092,371,132
减:所得税费用(53,305)343.71%(112,586)171,739276,924266,246
净利润1,029,581-11.75%1,482,5492,479,8952,402,2852,104,886
减:非控股权益6,879-20.10%(77,597)77,52250,23289,098
股东净利润1,022,702-11.69%1,560,1462,402,3742,352,0532,015,789

市场价值指针
每股收益 (元) *0.591-11.66%0.9021.3881.3591.631
每股派息 (元) *----0.2800.4200.6000.500
每股净资产 (元) *10.5316.58%10.1369.572--10.724
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容